Published in Am J Med Genet A on May 15, 2004
Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry (2010) 2.07
Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci (2010) 0.96
Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol Genet Genomics (2006) 0.95
Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome. Eur J Hum Genet (2011) 0.95
Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philos Trans R Soc Lond B Biol Sci (2013) 0.94
Genetic disruption of Met signaling impairs GABAergic striatal development and cognition. Neuroscience (2010) 0.89
Animal models of tic disorders: a translational perspective. J Neurosci Methods (2014) 0.87
Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. Eur J Hum Genet (2014) 0.84
Family-based association study of ZNF533, DOCK4 and IMMP2L gene polymorphisms linked to autism in a northeastern Chinese Han population. J Zhejiang Univ Sci B (2014) 0.83
Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorder. BMC Med Genet (2012) 0.82
From Genetics to Epigenetics: New Perspectives in Tourette Syndrome Research. Front Neurosci (2016) 0.77
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Mov Disord (2014) 2.64
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Exome sequencing identifies FUS mutations as a cause of essential tremor. Am J Hum Genet (2012) 2.30
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry (2012) 1.70
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder. Can J Psychiatry (2013) 1.61
Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J Clin Invest (2008) 1.61
NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet (2002) 1.51
A treatable new cause of chorea: beta-ketothiolase deficiency. Mov Disord (2013) 1.47
Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain (2014) 1.45
Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology (2012) 1.42
Mutations in DCC cause congenital mirror movements. Science (2010) 1.41
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet (2013) 1.33
Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet (2013) 1.31
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
C5orf42 is the major gene responsible for OFD syndrome type VI. Hum Genet (2013) 1.24
MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet (2009) 1.21
The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry (2010) 1.21
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov Disord (2012) 1.19
First-episode psychosis, early intervention, and outcome: what have we learned? Can J Psychiatry (2005) 1.18
Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci (2005) 1.18
Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics (2003) 1.17
Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci (2003) 1.17
Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis. Schizophr Res (2007) 1.14
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res (2004) 1.13
Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One (2009) 1.12
Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry (2012) 1.12
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci (2008) 1.10
Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord (2009) 1.09
LRRK2 is not a significant cause of Parkinson's disease in French-Canadians. Can J Neurol Sci (2007) 1.09
Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry (2012) 1.07
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci (2006) 1.07
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord (2005) 1.07
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology (2012) 1.05
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry (2008) 1.05
Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci (2011) 1.04
Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. Am J Med Genet A (2003) 1.03
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry (2011) 1.02
The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology (2011) 1.02
Education modulates cortisol reactivity to the Trier Social Stress Test in middle-aged adults. Psychoneuroendocrinology (2007) 1.01
Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.01
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. J Clin Psychiatry (2014) 0.99
A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol (2010) 0.99
Identification of metabolites related to mechanisms of resistance in barley against Fusarium graminearum, based on mass spectrometry. Plant Mol Biol (2011) 0.97
Effectiveness of a therapeutic summer camp for children with ADHD: Phase I Clinical Intervention Trial. J Atten Disord (2011) 0.97
Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry (2007) 0.97
Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res (2010) 0.96
Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res (2011) 0.96
No TARDBP mutations in a French Canadian population of patients with Parkinson disease. Arch Neurol (2009) 0.96
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res (2010) 0.96
Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease. Neurobiol Aging (2013) 0.95
Adult cases of congenital muscular torticollis successfully treated with botulinum toxin. Mov Disord (2010) 0.94
In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet (2012) 0.94
Cognitive insight and verbal memory in first episode of psychosis. Eur Psychiatry (2008) 0.94
Mass spectrometry-based metabolomics application to identify quantitative resistance-related metabolites in barley against Fusarium head blight. Mol Plant Pathol (2010) 0.94
Development and persistence of posttraumatic stress disorder and the 5-HTTLPR polymorphism. J Trauma Stress (2009) 0.93
Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci (2011) 0.93
Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. J Psychiatr Res (2009) 0.93
Mass spectrometry based metabolomics to identify potential biomarkers for resistance in barley against fusarium head blight (Fusarium graminearum). J Chem Ecol (2011) 0.92
Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis. Neurogenetics (2005) 0.91
Publication bias: what are the challenges and can they be overcome? J Psychiatry Neurosci (2012) 0.91
Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. Nicotine Tob Res (2012) 0.91
Investigation of C9orf72 repeat expansions in Parkinson's disease. Neurobiol Aging (2012) 0.91
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Serotonin transporter, stressful life events, and depression severity. Am J Psychiatry (2007) 0.90
Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep (2007) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis (2015) 0.90
Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet (2005) 0.89
Understanding putative risk factors for schizophrenia: retrospective and prospective studies. J Psychiatry Neurosci (2005) 0.88
The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci (2007) 0.88
Association of intronic variants of the BTBD9 gene with Tourette syndrome. Arch Neurol (2009) 0.88
Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology (2006) 0.88
LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry (2012) 0.87
Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. Behav Neurosci (2004) 0.87
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet (2013) 0.87
Maternal Stress during Pregnancy, ADHD Symptomatology in Children and Genotype: Gene-Environment Interaction. J Can Acad Child Adolesc Psychiatry (2012) 0.87
The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. Clin Schizophr Relat Psychoses (2011) 0.87
Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort. Can J Neurol Sci (2011) 0.87
The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front Psychiatry (2012) 0.87